Modulatory role of the mPFC orexin-2 receptors in the acquisition and expression in two paradigms of the natural- and drug-induced conditioned place preference in the rats.
Aug 2026· Behavioural Brain Research· pp.
116430
· 0 citations· 35 references
Medicine
TL;DR
A differential involvement of mPFC Orx2Rs in the acquisition and expression phases of CPP is proposed, suggesting distinguishable behavioral effects between food and morphine reward models, however, further mechanistic studies are required to clarify the underlying neural substrates.
Abstract
The neuropeptide orexin/hypocretin regulates adaptive behaviors needed for survival, including food intake, sleep-wake regulation, mating, and maternal behavior. However, the orexinergic system plays a critical role in addictive behavior and promotes seeking and rewarding substances of abuse and palatable food. Plenty of orexin receptors exist in the medial prefrontal cortex (mPFC). The PFC input to the NAc mediates goal-directed behaviors such as seeking behavior and planning actions to obtain rewarding substances. This study investigated the role of mPFC orexin-2 receptors (Orx2Rs) in natural-and drug-reward-seeking behaviors. One hundred sixteen adult male Wistar rats received TCS OX2 29 (3, 10, and 30 nmol/0.5µl DMSO 12%) as an Orx2R antagonist in the mPFC during the acquisition and expression phases of two different CPP paradigms, morphine- and food-induced CPP protocols. Findings demonstrated that intra-mPFC administration of Orx2R antagonist reduced the acquisition and expression of morphine- and food-induced CPP in the rats. However, blockades of Orx2Rs in the mPFC have more inhibitory effects in food-induced CPP than in morphine-induced CPP. In conclusion, this study proposes a differential involvement of mPFC Orx2Rs in the acquisition and expression phases of CPP, suggesting distinguishable behavioral effects between food and morphine reward models. However, further mechanistic studies are required to clarify the underlying neural substrates.
Objective The nucleus accumbens shell is a key region involved in motivation and reinforcement behavior associated with the consumption of palatable foods. However, it has not been studied whether D4 dopaminergic receptors regulate homeostatic feeding and reward-dependent behaviors. The objective of this study was to e...
J. G. Tejas-Juárez, Josué O. Suárez-Ortiz, R. E. Escartín-Pérez et al.· Frontiers in Psychology· 0 citations
Induction of innate fear decreased flinch frequency only during the first phase of the formalin test, and intra-BLA administration of orexin-A may retrogradely affect Cb1R-containing interneurons and increase Cb1R expression, thereby counteracting stress-induced analgesia.
Mahnaz Aghaei, R. Khakpay, Fatemeh Khakpai et al.· Neuropharmacology· 0 citations
The ability of MDMA to decrease ethanol intake in msP rats and to induce gene expression alterations of dynorphinergic and nociceptinergic systems within specific mesolimbic brain regions are indicated.
L. Rullo, L. M. Losapio, Hela Mrizak et al.· Neuropharmacology· 0 citations
This study explores the neural mechanisms underlying the communication between the hippocampus and the prelimbic cortex during the reinstatement phase of reward-seeking behavior in a conditioned place preference (CPP) paradigm. Rats were exposed to methamphetamine (METH) [0.5 and 0.25 mg/kg] and the impact of these dos...
The results suggest that increasing 2-AG, but not anandamide, in the VTA selectively enhances the choice to respond to cues predicting a reward, however, the effects of systemic MJN110 in enhancing the vigor of responding cannot be attributed to VTA 2-AG signaling.
Martin P. K. Leigh, Jaqlyn Colangelo, Malte Feja et al.· Neuropharmacology· 0 citations
The behavioral effects of the novel benzodiazepine-like compounds, HZ-166 and KRM-II-81, which show preferential efficacy for α2/3GABAA receptors, in comparison with the α1GABAA-selective compound, zolpidem, reinforce the role of α1GABAA receptors in benzodiazepine-induced sedation, cognitive impairment, and addiction...
V. A. Gundim, Hítalo C. da Silva, Roberta C. Dos Anjos Costa et al.· Journal of Psychopharmacolog...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.